Leadership Changes at MIT Corporation
As of 1st July 2018, Kiran Mazumdar Shaw, who is the Chairperson and Managing Director of India's largest biotechnology company, has been appointed to serve a five-year term on the…
ADC Therapeutics Discusses ZYNLONTA Strategy and Clinical Advancements
In a recent discussion, ADC Therapeutics provided insights into the ongoing developments surrounding its flagship product, ZYNLONTA. The conversation featured Ameet Mallik, the CEO of ADC Therapeutics, who elaborated on…
MeiraGTx Holdings plc at RBC Capital Markets Virtual Ophthalmology Conference
MeiraGTx Holdings plc at RBC Capital Markets Virtual Ophthalmology Conference Good morning, everyone. This is Lisa Walter, a Biotech Analyst from RBC Capital Markets. Thank you for attending the RBC's…
Insights into Market Drivers: Recent Advancements in the Biologic Hernia Repair Mesh Sector
The biologic hernia repair mesh market is on track for significant growth in the forthcoming years, fuelled by technological advancements and shifting clinical preferences. This report provides an in-depth analysis…
Support for the Re-Election of Jennifer Bryson and Michael Mercaldi to the Wilmington School Committee
Dear voters of Wilmington, It is with great enthusiasm that I encourage you to support the re-election of Jennifer Bryson and Michael Mercaldi to our school committee. Over the past…
Expansion at NU Advisory Partners with New Partner Additions
March 27, 2026 – NU Advisory Partners has announced the addition of Caitlin Maloof, Jessica Johnson, and Alan Mait as partners, further enhancing the firm's capabilities across key sectors and…
Clockwork Bio Emerges as an Innovative Force in Oncology Drug Discovery
Clockwork Bio has been established as a pioneering AI-native biotechnology company dedicated to advancing early-stage oncology drug discovery. The firm is developing a platform that focuses on modelling and controlling…
Navigating the Transition to Original Medicare: Considerations for Medigap Coverage
As the open enrollment period for Medicare Advantage (MA) approaches, individuals currently enrolled in private managed-care plans have the opportunity to either switch to a new plan or revert to…
Transgene to Present Individualized Neoantigen Therapeutic Vaccine TG4050 at World Vaccine Congress
Strasbourg, France, March 26, 2026, 5:45 p.m. CET – Transgene (Euronext Paris: TNG), a biotechnology firm dedicated to the design and development of virus-based immunotherapies for cancer treatment, has announced…
Peritia Welcomes Michael A. Griffith as Chief Executive Officer
MORRISVILLE, N.C. and NEW YORK, March 26, 2026 /PRNewswire/ -- Peritia, a prominent consulting firm in the biopharmaceutical and medtech sectors, has announced the appointment of Michael Griffith as Chief…